Globus Medical, Inc.

Equities

GMED

US3795772082

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
50.55 ^USD	+0.36%		+0.40%	-5.14%

Mar. 19	North American Morning Briefing : Stock Futures -2-	DJ
Mar. 18	BTIG Upgrades Globus Medical to Buy From Neutral, Price Target is $60	MT

Tranche Update on Globus Medical, Inc.'s Equity Buyback Plan announced on March 12, 2020.

February 21, 2024 at 06:14 am EST

From October 1, 2023 to December 31, 2023, the company has repurchased 4,329,000 shares, representing 3.08% for $225.59 million. With this, the company has completed the repurchase of 9,371,000 shares, representing 8.1% for $474.77 million under the buyback announced on March 12, 2020.

Latest news about Globus Medical, Inc.

North American Morning Briefing : Stock Futures -2-	Mar. 19	DJ
BTIG Upgrades Globus Medical to Buy From Neutral, Price Target is $60	Mar. 18	MT
Globus Medical Insider Sold Shares Worth $405,730, According to a Recent SEC Filing	Mar. 05	MT
Atkore Insider Sold Shares Worth $2,195,228, According to a Recent SEC Filing	Mar. 05	MT
Truist Securities Adjusts Price Target on Globus Medical to $60 From $58, Keeps Hold Rating	Feb. 21	MT
Stifel Adjusts Globus Medical's Price Target to $64 From $61, Keeps Buy Rating	Feb. 21	MT
Tranche Update on Globus Medical, Inc.'s Equity Buyback Plan announced on March 12, 2020.	Feb. 21	CI
Globus Medical Q4 Non-GAAP Earnings, Revenue Increase; Sets 2024 Guidance	Feb. 20	MT
Globus Medical, Inc. Reaffirms Revenue Guidance for the Full Year 2024	Feb. 20	CI
Transcript : Globus Medical, Inc., Q4 2023 Earnings Call, Feb 20, 2024	Feb. 20
Earnings Flash (GMED) GLOBUS MEDICAL Reports Q4 EPS $0.60, vs. Street Est of $0.61	Feb. 20	MT
Earnings Flash (GMED) GLOBUS MEDICAL Reports Q4 Revenue $616.5M, vs. Street Est of $608.2M	Feb. 20	MT
Globus Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 20	CI
Globus Medical, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 20	CI
Globus Medical Appoints CFO Keith Pfeil to Additional Role of Chief Operating Officer	Feb. 06	MT
Globus Medical Promotes Keith Pfeil to Chief Operating Officer	Feb. 05	CI
Global markets live: UBS, Netflix, Pfizer, Citigroup, Alphabet...	Jan. 11
Investors keep their cool despite inflation data	Jan. 11
Globus Medical Reports Preliminary Q4, 2023 Sales, Issues 2024 Profit, Revenue Guidance	Jan. 10	MT
Globus Medical, Inc. Provides Sales Results for the Fourth Quarter and Full Year Ending December 31, 2023; Provides Earnings Guidance for the Full Year Fiscal 2024	Jan. 10	CI
Truist Adjusts Price Target on Globus Medical to $58 From $53, Maintains Hold Rating	Dec. 22	MT
Canaccord Genuity Adjusts Globus Medical's Price Target to $71 From $67, Keeps Buy Rating	Dec. 20	MT
RBC Cuts Price Target on Globus Medical to $70 From $77, Keeps Outperform Rating	Nov. 24	MT
Morgan Stanley Cuts Price Target on Globus Medical to $53 From $60, Maintains Equalweight Rating	Nov. 14	MT
Truist Securities Adjusts Price Target on Globus Medical to $53 From $58, Maintains Hold Rating	Nov. 08	MT

Chart Globus Medical, Inc.

Duration

Period

More charts

Company Profile

Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-06 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Globus Medical, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

50.55 USD

Average target price

64.89 USD

Spread / Average Target

+28.36%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
GLOBUS MEDICAL, INC.	-5.14%	6.83B
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution